ReviewNature protocols2026
Iron-catalyzed stereoselective glycosylation for 1,2-cis-aminoglycoside assembly.
Review in Nature protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Advances in chemoenzymatic synthesis of glycosaminoglycans and proteoglycans.Current opinion in chemical biology · 2026Review
- Process Safety Assessment of the Iron-Catalyzed 1,2-Organic process research & development · 2026Article
- Iron Porphyrin Catalysts Induce Stereospecific Glycosylation with Glycal Epoxides.Synlett : accounts and rapid communications in synthetic organic chemistry · 2026Article
- Process Safety Assessment of the Iron-Catalyzed 1,2-Research square · 2026Article
- Merging Enzymatic Catalysis with Iron Catalysis for Highly Stereoselective Heparan Sulfate Oligosaccharide Assembly.Journal of the American Chemical Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Complex carbohydrates are essential to life processes, but it is challenging to isolate these molecules from natural sources in high homogeneity. Therefore, complex-glycan synthesis becomes critical to improving our understanding of their important functions. Due to their complexity, synthesis is still difficult for nonexperts. One of the key challenges is to search for general solutions for highly 1,2-cis-selective glycosylation, which will directly assemble 1,2-cis-2-aminoglycosides that are incorporated in numerous biologically important complex glycans and glycoconjugates. Here we describe an iron-catalyzed, chemical glycosylation method for rapid assembly of 1,2-cis-aminoglycosidic linkages. The iron catalyst is commercially available, and the bench-stable supporting ligand and amination reagents are easily prepared from abundant, readily available starting materials. This catalytic, exclusively 1,2-cis-selective glycosylation is effective for a broad range of glycosyl donors and acceptors, and it can be operated in a continuous fashion and scaled up to the multigram scale. The reactivity of this glycosylation is tunable for both electron-rich and electron-deficient substrates by modulating amination reagents. The glycosylation proceeds through a unique mechanism in which the iron catalyst activates a glycosyl acceptor and an oxidant when it facilitates the cooperative atom transfer of both moieties to a glycosyl donor in an exclusively cis-selective manner. This glycosylation protocol takes several hours to operate. It complements the existing 1,2-cis-selective glycosylation methods and effectively addresses the challenge of achieving both generality and high stereoselectivity in the 1,2-cis-selective aminoglycosylation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.